InvestorsHub Logo
Followers 11
Posts 294
Boards Moderated 0
Alias Born 08/27/2017

Re: None

Sunday, 09/06/2020 9:49:42 PM

Sunday, September 06, 2020 9:49:42 PM

Post# of 703809
One thing is for sure... If DCVAX-L is efficacious, DCVAX direct phase 3 will not take 10+ years for approval. I look for the stock price to surprise us all after release of positive topline data. Especially if we are on the verge of a new potential SOC, not just for GBM but also for all solid tumors. Once the world catches on to the potential benefit to all cancer patients, with it's safety profile included, we are looking at a game changer. Consequently, we should anticipate a share price to increase in the next year to at least double digits if we low ball it. However, I will never discount a share price up to and over $100 per share if this is a banger!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News